Education
About Us
Working with TipRanks
Follow Us
Treace Medical Concepts, Inc. (TMCI)
:TMCI
TMCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.54 - $10.79
Previous CloseN/A
Volume76.56K
Average Volume (3M)296.74K
Market Cap
$412.52M
Enterprise Value$371.29M
Total Cash (Recent Filing)$69.29M
Total Debt (Recent Filing)$70.09M
Price to Earnings (P/E)―
Beta1.95
Next Earnings
Nov 11, 2025EPS Estimate
-0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding63,173,126
10 Day Avg. Volume430,026
30 Day Avg. Volume296,742
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue1.74
Enterprise Value/Gross Profit2.17
Enterprise Value/Ebitda-10.76
Forecast
1Y Price Target
$8.33Price Target Upside27.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTreace reported Q4 results slightly higher than estimates and consensus, indicating strong performance.
Market OpportunitiesThe foot and ankle orthopedics market is a $5B+ global market growing at a 7%-8% CAGR, offering significant opportunities for attention.
New Product LaunchesThe introduction and expansion of new products like Nanoplasty, Percuplasty 3D MIS Osteotomy Systems, and SpeedMTP received positive feedback, indicating future growth potential.
Bears Say
Growth ConcernsLapiplasty growth has stalled, raising concerns about the company's growth profile in this area.
Market SentimentInvestors have experienced multiple significant drawdowns related to softness in bunion procedures and competitive concerns, causing many to move to the sidelines.
Treace Medical Concepts News
TMCI FAQ
What was Treace Medical Concepts, Inc.’s price range in the past 12 months?
Treace Medical Concepts, Inc. lowest stock price was $4.54 and its highest was $10.79 in the past 12 months.
What is Treace Medical Concepts, Inc.’s market cap?
Treace Medical Concepts, Inc.’s market cap is $412.52M.
When is Treace Medical Concepts, Inc.’s upcoming earnings report date?
Treace Medical Concepts, Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 88 days.
How were Treace Medical Concepts, Inc.’s earnings last quarter?
Treace Medical Concepts, Inc. released its earnings results on Aug 07, 2025. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.288 by $0.008.
Is Treace Medical Concepts, Inc. overvalued?
According to Wall Street analysts Treace Medical Concepts, Inc.’s price is currently Undervalued.
Does Treace Medical Concepts, Inc. pay dividends?
Treace Medical Concepts, Inc. does not currently pay dividends.
What is Treace Medical Concepts, Inc.’s EPS estimate?
Treace Medical Concepts, Inc.’s EPS estimate is -0.28.
How many shares outstanding does Treace Medical Concepts, Inc. have?
Treace Medical Concepts, Inc. has 63,173,126 shares outstanding.
What happened to Treace Medical Concepts, Inc.’s price movement after its last earnings report?
Treace Medical Concepts, Inc. reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.288. Following the earnings report the stock price went up 7.923%.
Which hedge fund is a major shareholder of Treace Medical Concepts, Inc.?
Currently, no hedge funds are holding shares in TMCI
Treace Medical Concepts Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.33 (27.57% Upside)
$8.33 (27.57% Upside)
Blogger Sentiment
Bullish
TMCI Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 967.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.67%
12-Months-Change
Fundamentals
Return on Equity
-46.89%
Trailing 12-Months
Asset Growth
-8.69%
Trailing 12-Months
Company Description
Treace Medical Concepts, Inc.
Treace Medical Concepts (TMCI) is a medical device company that specializes in the design, development, and commercialization of innovative surgical solutions for foot and ankle orthopedic procedures. The company is primarily focused on addressing unmet clinical needs in the treatment of bunions, leveraging its proprietary Lapiplasty 3D Bunion Correction System, which aims to improve surgical outcomes and patient recovery times.
TMCI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment due to the strong revenue growth, successful expansion of the product portfolio, and significant improvements in profitability metrics. However, there are some financial challenges such as a slight decline in gross margin and a decrease in cash reserves. The strategic initiatives and new product launches are expected to drive continued growth.View all TMCI earnings summariesTMCI Stock 12 Month Forecast
Average Price Target
$8.33
▲(27.57% Upside)
Technical Analysis
Ownership Overview
30.47% Insiders
12.08% Mutual Funds
0.09% Other Institutional Investors
44.81% Public Companies and
Individual Investors